Skip to search formSkip to main contentSkip to account menu

Ganciclovir:MCnc:Pt:XXX:Qn

Known as: ???????????:????????:??????:XXX:?????, Ganciclovir [Mass/volume] in Unspecified specimen, ????:????:???:XXX:??? 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The purpose of the present study was to formulate Solid Lipid Nanoparticles (SLNs) of Ganciclovir (GCV) in combination with… 
2013
2013
Congenital cytomegalovirus (CMV) infection is a major cause of birth defects and childhood disorders in the United States… 
2006
2006
A 60-year-old male on chemotherapy for multiple myeloma developed cytomegalovirus (CMV) retinitis in one eye. He was commenced on… 
2003
2003
PURPOSE To determine the optimal formulation of lipid prodrug, 1-O-hexadecyloxypropyl-phospho-ganciclovir (HDP-P-GCV), for… 
2002
2002
PURPOSE To evaluate an intraocular drug delivery system consisting of the crystalline ammonium salt of 1-O-hexadecylpropanediol-3… 
1996
1996
A retrospective study was made of 26 patients with AIDS who initially presented with retinitis as the only clinical manifestation… 
1996
1996
OBJECTIVE: To assess the evolution of cytomegalovirus (CMV) retinitis and evaluate the possible complications associated with the… 
1994
1994
Acyclovir phosphonate [9-(3-phosphono-propyloxymethyl)guanine; SR3722] and the S enantiomer (SR3772), R enantiomer (SR3773), and…